The effect of iron in different forms on the proliferative response to mitogen and ferritin content of human mononuclear leukocytes (MNL) was studied in vitro. Iron-loaded transferrin (FeTF) but not apotransferrin (apoTF) significantly enhanced the mitogenic response of MNL in serum-free culture. Removal of TF from serum markedly reduced its effectiveness as a serum supplement. This effect could be almost totally reversed when the serum was reconstituted with both iron and apoTF. Four forms of iron showed a stimulatory effect on ferritin synthesis in MNL in the increasing order : FeTF < iron nitrilotriacetate < iron citrate (molar ratio 1: 20) < iron citrate (1:1). The effect appeared to be correlated with their susceptibility to polymerization in aqueous solution. It is proposed that iron may a) enhance the mitogenic response of MNL, due probably to the physiological form of iron, FeTF, and b) stimulate ferritin synthesis, a protective reaction of the cell to toxic polymerized forms of the metal. lymphocytes ; transferrin ; iron ; ferritin It is well established that alterations of iron balance, particularly deficiency, adversely affect the capacity of humans and experimental animals to effect an immune response, although the underlying mechanisms involved have not been completely clarified . In attempts to understand such effects, the role of iron in cells of the immune system has been evaluated in vitro by measuring the response of lymphocytes to mitogen in the presence or absence of the metal. However, due to the requirement for serum (which contains iron) shown by lymphocytes in culture, results showing the effect of iron addition to such cultures cannot lead to unequivocal conclusions. Results
obtained using serum-free cultures have shown that transferrin (TF), the iron transport protein of plasma, can at least partially substitute for serum as a culture supplement (Iscove and Melchers 1978 ; Dillner-Centerlind et al. 1979 ; Soyano et al. 1985a ), although it is more probable that it is the iron carried by TF which is meeting the needs of the cells rather than the protein itself (Brock and MainouFowler 1983) .
A further complication in the study of the role of iron in lymphocyte metabolism and response to mitogens is the peculiar chemical "behaviour" of the metal in solution. Ionic iron can only exist under acidic conditions and rapidly hydrolyses to polymeric forms at neutral pH (Spiro et al. 1967a, b) . Polynuclear iron formed when iron salts commonly used in immunological studies of the metal are dissolved at physiological pH will bind nonspecifically to TF (Bates and Schlabach 1975) and to other serum proteins (Van der Heul et al. 1972 ). However, iron-chelate complexes such as iron nitrilotriacetic acid (FeNTA) are less susceptible to hydrolysis and have been used in iron studies, especially those concerning transferrin (Bates and Schlabach 1973) .
The leukocyte requirement for iron is also indicated by the fact that these cells contain and synthesize ferritin, the iron storage protein. Monocytes show a higher intracellular ferritin concentration than lymphocytes (Summers et al. 1974) , and various authors have reported an increase in ferritin synthesis in vitro by the former but not the latter in response to the presence of iron in the culture medium (Summers et al. 1975; Sarcione et al. 1977; Lema and Sarcione 1981) .
The present paper investigates the contribution of iron-transferrin (FeTF) to the permissive effect of serum on the response MNL to mitogen, and examines the stimulatory effect of different forms of iron on ferritin synthesis.
MATERIALS AND METHODS
Isolation, culture, and mitogenic stimulation of mononuclear leukocytes. Blood obtained from healthy volunteers was layered onto Ficoll-Hypaque for gradient separation of mononuclear leukocytes (MNL). The cells collected from the interface were washed three times in phosphate-buffered saline (PBS), counted, and resuspended at the appropriate concentration in RPMI 1640 medium containing L-glutamine (2 mmole/ml), penicillin (100 units ml), streptomycin (100,ug/ml) and sodium bicarbonate (2 mg/ml) (all from Gibco, Grand Island, NY, USA). Cell viability was monitored by Trypan Blue exclusion. In some experiments the cells were separated into adherent and non-adherent populations as described below. Triplicate cell cultures were set up in round bottom microtiter plates (Linbro, Flow Labs., Hamden, CT, USA) and incubated at 37°C in a final volume of 200,ul for 72 hr in a humidified atmosphere containing 5% CO2. Different supplements were added to the culture medium as described below. The cells were activated with varying doses of phytohemagglutinin (PHA, Pharmacia Fine Chemicals, Uppsala, Sweden). Eight hr before harvesting, 0.2 ,u Ci of tritiated thymidine (3H-TdR, New England Nuclear, Boston, MA, USA) was added to each well. The cells were harvested onto glass-fibre filters using a multiple automated sample harvester (MASH II, Microbiological Lab., Bethesda, MD, USA). Incorporation of 3H-TdR was measured in a Packard liquid scintillation counter.
The proliferative response of MNL to a given dose of a mitogen such as PHA varies considerably according to the type of PHA and among individual donors. It was found that the effect of different supplements on the MNL in culture depended on their degree of activation, rather than on the absolute concentration of the mitogen. For this reason, the results presented below are expressed in terms of the degree of activation. A range of doses of mitogen was used in each experiment and the optimal responsed determined. A response between 25 and 75% of the optimal was classified as suboptimal.
Culture supplements. Ferric citrate was prepared from the chloride as follows. Ferric hydroxide was precipitated from an aqueous solution of FeCl3 (Merck & Co., Rahway, NJ, USA) with ammonium hydroxide solution. The precipitate was compacted by centrifugation at 2,000 g for 15 min then redissolved in an aqueous solution of citric acid with heating in a water bath. Ferric citrate (1 mM with respect to iron) at two different iron : citrate molar ratios was prepared, l : l and 1: 20. The pH was adjusted to 7.3 with 0.01 N sodium hydroxide.
Iron nitrilotriacetate was prepared as a 10 mM stock solution from ferric citrate with the nitrilotriacetate in equimolar proportions or in a 5-fold excess.
The serum used as a supplement was from a pool of inactivated sera from at least 10 healthy donors. Transferrin-free serum was prepared by incubating serum diluted to 10% in RPMI 1640 medium for 24 hr at 4°C in the presence of anti-transferrin antibody (Dakoimmunoglobulins a/s, Denmark) coupled to CNBr-activated Sepharose 4B (Pharmacia). Trace amounts of transferrin labelled with 59Fe were added to the serum to monitor the elimination of the transferrin. A control serum was prepared in exactly the same way except that it was incubated with bovine albumin (Fraction V, Sigma Chemical Co., St. Louis, M0, USA) coupled to Sepharose.
Crystallized human transferrin (essentially iron-free, Sigma) was either dissolved in RPMI 1640 medium for direct addition to the cultures, or saturated with FeNTA (1: 5) according to the method of Bates and Schlabach (1973) . The FeTF solution was dialysed against PBS containing 5 mM sodium bicarbonate to remove unbound iron.
Ferritin content of MNL. For the studies on ferritin, MNL were separated into adherent and non-adherent cells by incubation, twice, on plastic tissue culture plates in the presence of 10% pooled human serum for 45 min at 37°C. The cells were counted before and after adherent cell depletion, the difference being taken as the adherent cell count. Adherent cells were scraped off the bottom of the plate with a rubber policeman and prepared for the ferritin assay as described below. The ferritin concentration of the non-adherent cells was assayed directly, or the cells were cultured for 48 hr at a concentration of 4 x 105 cells/200,u1 in the presence of different supplements and activated with PHA at a final concentration of 1.25,ug/ml. For all the cell preparations, the cells were disrupted by adding Tween 20 (Merck) to a final concentration of 1% and also by 2 cycles of freezing and thawing. The disrupted cells were centrifuged at 12,000 g for 15 min and the ferritin concentration in the supernatant measured by a 2-site immunoradiometric assay (Miles et al. 1974 ).
Statistical analysis. Values were given in terms of mean +s.D. Differences between mean values were analysed by Student's t-test and judged to be significant when p values were less than 0.05.
RESULTS
The permissive effect of both apoTF and FeTF on the MNL response to the mitogen PHA in serum-free medium was investigated using cultures of 4>< 105 cells/well. Table 1 shows that both iron-free and iron-loaded TF at a concentration of 0.6 p M increased the response of the cells to optimal doses of the mitogen. However this effect was only significant with respect to the control cultures in the case of the iron-loaded TF (p <0.01). In addition, the permissive effect of the FeTF was significantly greater than that of the apoTF (p <0.01). The permissive effect of both forms of TF was much reduced at suboptimal doses of mitogen, and in the absence of mitogen FeTF showed a significantly negative effect (p <0.01) on the basal activity of the cells. Table 2 shows the results of a typical experiment to investigate the role of transferrin in the enhancing effect of serum on the MNL response to PHA. Removal of transferrin from the serum used as a culture supplement reduced the , only FeTF showed a significantly positive effect on the ability of MNL to respond to mitogen in serum-free culture. To determine the effect of 4 different forms of iron on the cellular iron metabolism and cell activation, the ferritin concentration of cells was studied in parallel with tritiated thymidine uptake.
The ferritin concentration in the adherent and non-adherent mononuclear cells of 6 normal subjects was measured. The non-adherent cells showed a mean ferritin concentration of 4.9 + 1.7 f g/cell, and the adherent population 9.1 + 3.5 f g/ cell. Table 3 Recent evidence strongly suggests that this effect is solely due to its iron-donating capacity ) although it is possible that transferrin may act as a growth factor (Brock and Mainou-Fowler 1983) . Here, we focus on the role of transferrin as an iron donor.
It has been reported that the addition of iron in forms other than FeTF may lead to both inhibition and enhancement of the lymphocyte response to mitogens. Iron citrate has been shown to be inhibitory under certain conditions (Bryan and Leech 1983; Soyano et al. 1985b ) while other iron compounds such as hemoglobin and ferritin have been reported to increase the response of lymphocytes to mitogens in serum-free culture (Tanno et al. 1982) . It is evident that the effect of iron on the lymphocyte response is very dependent on the conditions of culture, the presence of serum, the type and concentration of mitogen, and the form of iron used. Like other authors (Munn et al. 1981 ; Bryan and Leech 1983), we have observed that iron may show an inhibitory effect at suboptimal concentrations of mitogen and a slight stimulatory effect at supraoptimal doses (results not shown). A similar effect was observed with FeTF, which significantly inhibited the basal activation of unstimulated cells. It is possible that since the iron supply is not limiting in unstimulated cells, that they are not responsive in terms of an increased thymidine uptake to the presence of FeTF, thus revealing a slight negative effect, perhaps due to polynuclear iron which may be present in preparations of FeTF (Smit et al. 1981 ). Fernandez (1984) found that ferric citrate inhibited the lymphocyte response to PHA in the presence of 1% serum by 50%, but that at 5% serum and above this inhibition was reduced to less than 20%. In addition, ferric citrate prepared at a 1:1 molar ratio was shown to be more inhibitory than when the ratio of iron to citrate was 1: 20 (Soyano et al. 1985b ). Such results may be due to the peculiar chemistry of iron. It is possible that polynuclear iron formed under these conditions may bind non-specifically to the cell and exert a toxic effect. Serum proteins could by binding this toxic form of iron protect the cell. In experiments with 59FeC13, we have found that up to 100 times more iron in this form binds to human lymphocytes than when in the form of 59FeTF. In addition, the presence of serum in the medium may reduce the capture of iron from 59FeC13 by more than 10-fold (results to be published elsewhere).
As far as we can determine from the literature, there has been no published demonstration of the importance of TF in the permissive effect of serum on the response of lymphocytes to mitogen using the approach described here. It is evident from the results that the role of TF in the serum effect is substantial.
To investigate the effect of iron on these cultures, the iron was prepared at a 1:1 Fe: NTA molar ratio instead of 1: 5 to avoid the inhibitory effect of excess NTA. Although there is more likelihood of hydrolysis under such conditions, it is evident that the addition of iron to the cultures led to an increase in the response when unsaturated TF was present, not when absent, or present in an already partially saturated form. In other words, neither TF nor Fe alone are effective in permitting an increased thymidine uptake. Only when the iron is added to transferrin-containing culture, is it effectively and physiologically taken up by the activated cells allowing a greater degree of activation.
Several authors have reported the ferritin content of lymphocytes and monocytes. Our results for lymphocytes are comparable to those of Summers et al. (1974) but somewhat lower than those of Phillips and Rutledge (1984) . The latter authors reported an increase in ferritin synthesis by leukocytes in response to both mitogenic activation and addition of iron to the medium. However, the majority of authors have found that monocytes but not lymphocytes show an increase in ferritin synthesis in response to iron. One explanation for the differing results is that Phillips and Rutledge did not separate out the adherent cell population, although it is doubtful whether their lymphocyte preparation contained enough monocytes to explain the results since "virtually all cells isolated were small lymphocytes".
The results presented here suggest another possible explanation, that is, that only polynuclear iron stimulates ferritin synthesis in lymphocytes. Results of other authors showing a limited or absent synthesis were performed in cultures containing from 10 to 20% serum which may bind the polynuclear iron and thus "protect" the lymphocytes as suggested above. In addition, the iron was generally added as ferric ammonium citrate, one of the forms of iron more resistant to polymerization. Our results are more comparable to those of Phillips and Rutledge, in that we used serum-free cultures. Our results show that the iron forms in increasing order of susceptibility to polymerization, FeTF < FeNTA (1:1) < Fe citrate (1: 20) < Fe citrate (1:1) (H. Pons, personal communication) show the same order in terms of their stimulatory effect on ferritin synthesis, and inhibitory effect on cell activation. Like Phillips and Rutledge, we found that our preparation of FeTF also increased ferritin synthesis. This may be due to the presence of polynuclear iron in such preparations or to the fact that iron bound specifically to transferrin does in fact stimulate ferritin synthesis.
In conclusion, we suggest that lymphocytes may take up, or respond to iron in the medium in two different ways, with two different results : a) Physiological iron uptake from transferrin under the control of the cell metabolism and specific receptors on the cell surface. Iron taken up in this form may be used immediately by the cell and thus permit an increase in the cellular metabolic response to mitogens. b) Uncontrolled non-specific capture of polymerized iron by the cell surface. This capture may have a toxic effect and provoke ferritin synthesis by the cell as a protective reaction.
